Surgical treatment of liver metastases;Chirurgische Therapie von Lebermetastasen

Chirurg

Volumn 81, Issue 6, 2010, Pages 533-541

  Loss, M ^a   Jung, E M ^a   Scherer, M N ^a   Farkas, S A ^a   Schlitt, H J ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Liver metastases; Procedure; Surgical strategies; Surgical treatment

Indexed keywords

ADJUVANT THERAPY; AGED; ARTICLE; CANCER STAGING; CATHETER ABLATION; CHEMOEMBOLIZATION; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

AGED; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; SURVIVAL RATE;

EID: 77954088026     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-010-1891-9     Document Type: Article

References (55)

1. Ariff B, Lloyd CR, Khan S et al (2009) Imaging of liver cancer. World J Gastroenterol 15: 1289-1300.
2. Conlon R, Jacobs M, Dasgupta D, Lodge JP (2003) The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 16: 211-216.
3. Jung EM, Schreyer AG, Schacherer D et al (2009) New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results. Clin Hemorheol Microcirc 43: 57-69.
4. Cervone A, Sardi A, Conaway GL (2000) Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 66: 611-615.
5. Hogemann D, Stamm G, Shin H et al (2000) Individual planning of liver surgery interventions with a virtual model of the liver and its associated structures. Radiologe 40: 267-273.
6. Hansen C, Zidowitz S, Hindennach M et al (2009) Interactive determination of robust safety margins for oncologic liver surgery. Int J Comput Assist Radiol Surg 4: 469-474.
7. Carty SE, Jensen RT, Norton JA (1992) Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 12: 1024-1031; discussion 1031-022.
8. Hoti E, Adam R (2008) Liver transplantation for primary and metastatic liver cancers. Transpl Int 1: 1107-1117.
9. Rosenberg R, Stangl M, Siewert JR (2006) Chirurgische Therapie von Lebermetastasen. In: Siewert JR, Rothmund M, Schumpelick V (Hrsg) Praxis der Viszeralchirurgie. 2. Aufl. Springer, Berlin Heidelberg, S 575-586.
10. Musholt TJ, Lang H (2009) Indications and operative procedures for neuroendocrine liver metastases. Chirurg 80: 113-121.
11. Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77: 1254-1262.
12. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321.
13. Sharma S, Camci C, Jabbour N (2008) Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg 15: 570-580.
14. Nordlinger B, van Cutsem E, Rougier P et al (2007) Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the european colorectal metastases treatment group. Eur J Cancer 43: 2037-2045.
15. van Cutsem E, Nordlinger B, Adam R et al (2006) Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 42: 2212-2221.
16. Nordlinger B, van Cutsem E, Gruenberger T et al (2009) Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 20: 985-992.
17. Rubbia-Brandt L, Audard V, Sartoretti P et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466.
18. Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072.
19. Ward J, Guthrie JA, Sheridan MB et al (2008) Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 26: 4304-4310.
20. Aloia T, Sebagh M, Plasse M et al (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24: 4983-4990.
21. Welsh FK, Tilney HS, Tekkis PP et al (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96: 1037-1042.
22. Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
23. Falcone A, Ricci S, Brunetti I et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25: 1670-1676.
24. Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224: 509-520; discussion 520-502.
25. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
26. Barone C, Nuzzo G, Cassano A et al (2007) Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer 97: 1035-1039.
27. Folprecht G, Gruenberger T, Bechstein WO et al (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11: 38-47.
28. Sasanuma H, Yasuda Y, Mortensen FV et al (2006) Simultaneous colorectal and liver resections for synchronous colorectal metastases. Scand J Surg 95: 176-179.
29. Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197: 233-241; discussion 241-232.
30. Jenkins LT, Millikan KW, Bines SD et al (1997) Hepatic resection for metastatic colorectal cancer. Am Surg 63: 605-610.
31. Stewart GD, O'Suilleabhain CB, Madhavan KK et al (2004) The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 30: 370-376.
32. Finch RJ, Malik HZ, Hamady ZZ et al (2007) Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg 94: 1242-1248.
33. Gold JS, Are C, Kornprat P et al (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247: 109-117.
34. Zorzi D, Mullen JT, Abdalla EK et al (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10: 86-94.
35. Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94: 274-286.
36. Cady B, Jenkins RL, Steele GD Jr et al (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227: 566-571.
37. Shirabe K, Takenaka K, Gion T et al (1997) Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84: 1077-1080.
38. Pawlik TM, Scoggins CR, Zorzi D et al (2006) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241: 715-724.
39. Figueras J, Burdio F, Ramos E et al. (2007) Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 18: 1190-1195.
40. Are C, Gonen M, Zazzali K et al (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246: 295-300.
41. Haas RJ de, Wicherts DA, Flores E et al (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248: 626-637.
42. Nguyen KT, Gamblin TC, Geller DA (2009) World review of laparoscopic liver resection - 2, 804 patients. Ann Surg 250: 831-841.
43. Kooby DA, Stockman J, Ben-Porat L et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237: 860-869; discussion 869-870.
44. Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34: 267-272.
45. Fujii Y, Shimada H, Endo I et al (2000) Changes in clinicopathological findings after portal vein embolization. Hepatogastroenterology 47: 1560-1563.
46. Farges O, Belghiti J, Kianmanesh R et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237: 208-217.
47. Adam R, Laurent A, Azoulay D et al (2000) Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232: 777-785.
48. Tanaka K, Shimada H, Matsuo K et al (2007) Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 33: 329-335.
49. Kianmanesh R, Farges O, Abdalla EK et al (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197: 164-170.
50. Ihse I, Persson B, Tibblin S (1995) Neuroendocrine metastases of the liver. World J Surg 19: 76-82.
51. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242: 158-171.
52. Pawlik TM, Izzo F, Cohen DS et al (2003) Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10: 1059-1069.
53. Berber E, Pelley R, Siperstein AE (2005) Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23: 1358-1364.
54. Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-825; discussion 825-817.
55. Curley SA (2003) Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10: 338-347.